MEOBF Stock Price, Chart, Stats & News

Mesoblast Limited, an Australian biopharmaceutical company established in Melbourne in 2004, specializes in the development and global commercialization of allogeneic cellular medicines. With operations spanning the United States, Australia, Singapore, the United Kingdom, and Switzerland, the firm leverages a proprietary regenerative medicine platform based on specialized mesenchymal lineage cells. This technology underpins treatments for a wide spectrum of conditions, including cardiovascular, spinal orthopedic, oncological, hematological, immune-mediated, and inflammatory diseases.